370 related articles for article (PubMed ID: 17344291)
21. Analysis of a novel defective HTLV-I provirus and detection of a new HTLV-I-induced cellular transcript.
Kubota S; Furuta RA; Siomi H; Maki M; Hatanaka M
FEBS Lett; 1995 Nov; 375(1-2):31-6. PubMed ID: 7498474
[TBL] [Abstract][Full Text] [Related]
22. [HTLV-1 bZIP Factor (HBZ): Roles in HTLV-1 Oncogenesis].
Wu W; Cheng W; Chen M; Xu L; Zhao T
Bing Du Xue Bao; 2016 Mar; 32(2):235-42. PubMed ID: 27396170
[TBL] [Abstract][Full Text] [Related]
23. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.
Koiwa T; Hamano-Usami A; Ishida T; Okayama A; Yamaguchi K; Kamihira S; Watanabe T
J Virol; 2002 Sep; 76(18):9389-97. PubMed ID: 12186921
[TBL] [Abstract][Full Text] [Related]
24. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
Barbeau B; Mesnard JM
Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo.
Mortreux F; Leclercq I; Gabet AS; Leroy A; Westhof E; Gessain A; Wain-Hobson S; Wattel E
J Natl Cancer Inst; 2001 Mar; 93(5):367-77. PubMed ID: 11238698
[TBL] [Abstract][Full Text] [Related]
26. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.
Tsukasaki K; Tsushima H; Yamamura M; Hata T; Murata K; Maeda T; Atogami S; Sohda H; Momita S; Ideda S; Katamine S; Yamada Y; Kamihira S; Tomonaga M
Blood; 1997 Feb; 89(3):948-56. PubMed ID: 9028326
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.
Lemasson I; Lewis MR; Polakowski N; Hivin P; Cavanagh MH; Thébault S; Barbeau B; Nyborg JK; Mesnard JM
J Virol; 2007 Feb; 81(4):1543-53. PubMed ID: 17151132
[TBL] [Abstract][Full Text] [Related]
28. [Clonal expansion and genomic characterization of the human T-cell lymphotropic virus type I during the integration process in adult T-cell leukemia/lymphoma].
Salcedo-Cifuentes M; Cabrera J; Cuesta-Astroz Y; Carrasca E; Eizuru Y; Domínguez MC; Sánchez A; García-Vallejo F
Biomedica; 2009 Jun; 29(2):218-31. PubMed ID: 20128347
[TBL] [Abstract][Full Text] [Related]
29. Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states.
Doi K; Wu X; Taniguchi Y; Yasunaga J; Satou Y; Okayama A; Nosaka K; Matsuoka M
Blood; 2005 Aug; 106(3):1048-53. PubMed ID: 15840694
[TBL] [Abstract][Full Text] [Related]
30. Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1.
Laverdure S; Polakowski N; Hoang K; Lemasson I
J Virol; 2016 Jan; 90(7):3600-10. PubMed ID: 26792732
[TBL] [Abstract][Full Text] [Related]
31. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
[TBL] [Abstract][Full Text] [Related]
32. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia.
Chou KS; Okayama A; Su IJ; Lee TH; Essex M
Int J Cancer; 1996 Jan; 65(1):20-4. PubMed ID: 8543390
[TBL] [Abstract][Full Text] [Related]
33. [Recent progress in ATL and HTLV-1 research].
Matsuoka M
Rinsho Ketsueki; 2008 Oct; 49(10):1508-14. PubMed ID: 18833935
[No Abstract] [Full Text] [Related]
34. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.
Hagiya K; Yasunaga J; Satou Y; Ohshima K; Matsuoka M
Retrovirology; 2011 Mar; 8():19. PubMed ID: 21414204
[TBL] [Abstract][Full Text] [Related]
35. Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.
Raval GU; Bidoia C; Forlani G; Tosi G; Gessain A; Accolla RS
Retrovirology; 2015 Jul; 12():59. PubMed ID: 26140924
[TBL] [Abstract][Full Text] [Related]
36. Human T-lymphotropic virus type I genome in adult T-cell leukemia/lymphoma.
Yang YC; Hsu TY; Wang CH; Su IJ; Chen JY; Yang CS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):84-94. PubMed ID: 1935371
[TBL] [Abstract][Full Text] [Related]
37. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
[TBL] [Abstract][Full Text] [Related]
39. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
[TBL] [Abstract][Full Text] [Related]
40. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
Matsuoka M
Mol Aspects Med; 2010 Oct; 31(5):359-66. PubMed ID: 20599553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
